SEC Comment Letter 0000000000-22-013074 to Advaxis, Inc. (ADXS) (CIK 0001100397)
Advaxis, Inc. (ADXS) (CIK 0001100397)
Date: Dec. 5, 2022 · CIK: 0001100397 · Accession: 0000000000-22-013074
AI Filing Summary & Sentiment
File numbers found in text: 333-268586
Letter
United States securities and exchange commission logo December 5, 2022 Kenneth A. Berlin President and Chief Executive Officer Advaxis, Inc. 9 Deer Park Drive, Suite K-1 Monmouth Junction, New Jersey 08852 Re:Advaxis, Inc. Registration Statement on Form S-4 Filed November 29, 2022 File No. 333-268586 Dear Kenneth A. Berlin: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Justin W. Chairman
Show Raw Text
United States securities and exchange commission logo
December 5, 2022
Kenneth A. Berlin
President and Chief Executive Officer
Advaxis, Inc.
9 Deer Park Drive, Suite K-1
Monmouth Junction, New Jersey 08852
Re:Advaxis, Inc.
Registration Statement on Form S-4
Filed November 29, 2022
File No. 333-268586
Dear Kenneth A. Berlin:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Justin W. Chairman